Wall Street Lifts Lilly Target Past $1,200

Analysts raised their average target on LLY to $1,218 on Friday. That is the highest consensus figure among today's notable changes. The pharma giant carries a near-unanimous buy rating — 22 out of 28 analysts recommend buying the stock. Its market cap sits just shy of $980 billion.

ALB also saw a positive target revision. Albemarle's consensus target edged up to $214.65 from $213.97. The lithium miner trades with SI % FF of 9.1%, suggesting some shorts remain skeptical of a recovery.

On the downside, ACN took a target price cut. Accenture's average target fell to $200.89 from $208.16. The IT services giant holds a $78.6 billion market cap. Analyst views remain split — 15 hold ratings versus 13 buys.

LULU also absorbed a target reduction. lululemon's consensus target dropped to $132.16 from $133.74. Two analysts now carry sell ratings. Short interest stands at 7.5% of free float.

KIM, the REIT operator, bucked the trend. Its consensus target nudged up to $25.82 from $25.77. Real estate names are drawing renewed analyst attention as rate expectations shift.

DDOG picked up a new recommendation from an analyst. Its average target held near $241. The cloud monitoring firm commands 43 buy ratings — one of the strongest buy-side tilts in the current data.